[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R., Torre, L. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal, 68, 394-424. https://doi.org/10.3322/caac.21492
|
[2]
|
Ilic, M. and Ilic, I. (2016) Epidemiology of Pancreatic Cancer. World Journal of Gastroenterology, 22, 9694-9705.
https://doi.org/10.3748/wjg.v22.i44.9694
|
[3]
|
Lee, E.S. and Lee, J.M. (2014) Imaging Diagnosis of Pancreatic Cancer: A State-of-the-Art Review. World Journal of Gastroenterology, 20, 7864-7877. https://doi.org/10.3748/wjg.v20.i24.7864
|
[4]
|
Yoon, S.H., Lee, J.M., Cho, J.Y., et al. (2011) Small (≤20 mm) Pancreatic Adenocarcinomas: Analysis of Enhancement Patterns and Secondary Signs with Multiphasic Multide-tector CT. Radiology, 259, 442-452.
https://doi.org/10.1148/radiol.11101133
|
[5]
|
Chu, A.J., Lee, J.M., Lee, Y.J., Moon, S.K., Han, J.K. and Choi, B.I. (2012) Dual-Source, Dual-Energy Multidetector CT for the Evaluation of Pancreatic Tumours. The British Journal of Radiology, 85, e891-e898.
https://doi.org/10.1259/bjr/26129418
|
[6]
|
Goo, H.W. and Goo, J.M. (2017) Dual-Energy CT: New Horizon in Medical Imaging. Korean Journal of Radiology, 18, 555-569. https://doi.org/10.3348/kjr.2017.18.4.555
|
[7]
|
Agrawal, M.D., Pinho, D.F., Kulkarni, N.M., Hahn, P.F., Guimaraes, A.R. and Sahani, D.V. (2014) Oncologic Applications of Dual-Energy CT in the Abdomen. Radi-oGraphics, 34, 589-612. https://doi.org/10.1148/rg.343135041
|
[8]
|
De Cecco, C.N., Darnell, A., Rengo, M., et al. (2012) Dual-Energy CT: Oncologic Applications. American Journal of Roentgenology, 199, 98-105. https://doi.org/10.2214/AJR.12.9207
|
[9]
|
McLaughlin, P.D., Mallinson, P., Lourenco, P. and Nicolaou, S. (2015) Dual-Energy Computed Tomography: Advantages in the Acute Setting. Radiologic Clinics of North America, 53, 619-638.
https://doi.org/10.1016/j.rcl.2015.02.016
|
[10]
|
Marin, D., Nelson, R.C., Barnhart, H., et al. (2010) Detection of Pancreatic Tumors, Image Quality, and Radiation Dose during the Pancreatic Parenchymal Phase: Effect of a Low-Tube-Voltage, High-Tube-Current CT Technique-Preliminary Results. Radiology, 256, 450-459. https://doi.org/10.1148/radiol.10091819
|
[11]
|
Yamamura, S., Oda, S., Utsunomiya, D., et al. (2013) Dynamic Computed Tomography of Locally Advanced Pancreatic Cancer: Effect of Low Tube Voltage and a Hybrid Iterative Reconstruction Algorithm on Image Quality. Journal of Computer Assisted Tomography, 37, 790-796. https://doi.org/10.1097/RCT.0b013e318296db2b
|
[12]
|
Noda, Y., Kanematsu, M., Goshima, S., et al. (2014) Reduction of Iodine Load in CT Imaging of Pancreas Acquired with Low Tube Voltage and an Adaptive Statistical Iterative Reconstruction Technique. Journal of Computer Assisted Tomography, 38, 714-720. https://doi.org/10.1097/RCT.0000000000000106
|
[13]
|
Kim, J.H., Lee, J.M., Park, J.H., et al. (2013) Solid Pancreatic Lesions: Characterization by Using Timing Bolus Dynamic Contrast-Enhanced MR Imaging Assess-ment—A Preliminary Study. Radiology, 266, 185-196.
https://doi.org/10.1148/radiol.12120111
|
[14]
|
Bashir, U., Mallia, A., Stirling, J., et al. (2015) PET/MRI in Oncological Imaging: State of the Art. Diagnostics, 5, 333-357. https://doi.org/10.3390/diagnostics5030333
|
[15]
|
Wehrl, H.F., Sauter, A.W., Divine, M.R. and Pichler, B.J. (2015) Combined PET/MR: A Technology Becomes Mature. Journal of Nuclear Medicine, 56, 165-168. https://doi.org/10.2967/jnumed.114.150318
|
[16]
|
Bang, J.Y., Kirtane, S., Krall, K., et al. (2018) In Memori-am-Fine Needle Aspiration, Birth-Fine Needle Biopsy: The Changing Trend in Endoscopic Ultrasound-Guided Tissue Acquisition. Digestive Endoscopy, 31, 197-202.
https://doi.org/10.1111/den.13280
|
[17]
|
Zhang, Y., Yang, J., Li, H., Wu, Y., Zhang, H. and Chen, W. (2015) Tumor Markers CA19-9, CA242 and CEA in the Diagnosis of Pancreatic Cancer: A Meta-Analysis. International Journal of Clinical and Experimental Medicine, 8, 11683-11691.
|
[18]
|
Halkova, T., Cuperkova, R., Minarik, M. and Benesova, L. (2015) MicroRNAs in Pancreatic Cancer: Involvement in Carcinogenesis and Potential Use for Di-agnosis and Prognosis. Gastroenterology Research and Practice, 2015, Article ID: 892903. https://doi.org/10.1155/2015/892903
|
[19]
|
Subramani, R., Gangwani, L., Nandy, S.B., Arumugam, A., Chat-topadhyay, M. and Lakshmanaswamy, R. (2015) Emerging Roles of MicroRNAs in Pancreatic Cancer Diagnosis, Therapy and Prognosis (Review). International Journal of Oncology, 47, 1203-1210. https://doi.org/10.3892/ijo.2015.3129
|
[20]
|
Tian, X., Shivapurkar, N., Wu, Z., et al. (2016) Circulating Mi-croRNA Profile Predicts Disease Progression in Patients Receiving Second-Line Treatment of Lapatinib and Cape-citabine for Metastatic Pancreatic Cancer. Oncology Letters, 11, 1645-1650. https://doi.org/10.3892/ol.2016.4101
|
[21]
|
Bhagwat, N., Dulmage Jr., K., et al. (2018) An Integrated Flow Cytometry-Based Platform for Isolation and Molecular Characterization of Circulating Tumor Single Cells and Clusters. Scientific Reports, 8, 5035.
https://doi.org/10.1038/s41598-018-23217-5
|
[22]
|
Gao, Y., Zhu, Y. and Yuan, Z. (2016) Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer. International Journal of Medical Sciences, 13, 902-913. https://doi.org/10.7150/ijms.16734
|
[23]
|
Kolostova, K., Rzechonek, A., Schützner, J.A.N. and Grill, R. (2017) Circulating Tumor Cells as an Auxiliary. In Vivo, 31, 1197-1202. https://doi.org/10.21873/invivo.11190
|
[24]
|
Desjobert, C., El Maï, M., Gérard-Hirne, T., et al. (2015) Combined Analysis of DNA Methylation and Cell Cycle in Cancer Cells. Epigenetics, 10, 82-91. https://doi.org/10.1080/15592294.2014.995542
|
[25]
|
Yi, J.M., Guzzetta, A.A., Bailey, V.J., et al. (2013) Novel Methylation Biomarker Panel for the Early Detection of Pancreatic Cancer. Clinical Cancer Research, 19, 6544-6555. https://doi.org/10.1158/1078-0432.CCR-12-3224
|
[26]
|
Melo, S.A., Luecke, L.B., Kahlert, C., et al. (2015) Glypican1 Identifies Cancer Exosomes and Facilitates Early Detection of Cancer. Nature, 523, 177-182. https://doi.org/10.1038/nature14581
|
[27]
|
Tan, C., Zhang, H., Peng, B. and Li, K. (2015) Outcome and Costs of Laparoscopic Pancreaticoduodenectomy during the Initial Learning Curve vs Laparotomy. World Journal of Gas-troenterology, 21, 5311-5319.
https://doi.org/10.3748/wjg.v21.i17.5311
|
[28]
|
Handgraaf, H.J.M., Boonstra, M.C., Van Erkel, A.R., et al. (2014) Current and Future Intraoperative Imaging Strategies to Increase Radical Resection Rates in Pancreatic Cancer Surgery. BioMed Research International, 2014, 1-8.
https://doi.org/10.1155/2014/890230
|
[29]
|
de Werra, C., Quarto, G., Aloia, S., et al. (2015) The Use of In-traoperative Ultrasound for Diagnosis and Stadiation in Pancreatic Head Neoformations. International Journal of Surgery, 21, S55-S58.
https://doi.org/10.1016/j.ijsu.2015.04.091
|
[30]
|
Nelson, D.W., Blanchard, T.H., Causey, M.W., et al. (2013) Examining the Accuracy and Clinical Usefulness of Intraoperative Frozen Section Analysis in the Management of Pancreatic Lesions. The American Journal of Surgery, 205, 613-617. https://doi.org/10.1016/j.amjsurg.2013.01.015
|
[31]
|
Vahrmeijer, A.L., Hutteman, M., van der Vorst, J.R., van de Velde, C.J.H. and Frangioni, J.V. (2013) Image-Guided Cancer Surgery Using Near-Infrared Fluorescence. Na-ture Reviews Clinical Oncology, 10, 507-518.
https://doi.org/10.1038/nrclinonc.2013.123
|
[32]
|
Yano, S., Hiroshima, Y., Maawy, A., et al. (2015) Col-or-Coding Cancer and Stromal Cells with Genetic Reporters in a Patient-Derived Orthotopic Xenograft (PDOX) Model of Pancreatic Cancer Enhances Fluorescence-Guided Surgery. Cancer Gene Therapy, 22, 344-350. https://doi.org/10.1038/cgt.2015.26
|
[33]
|
Muranaka, T., Kuwatani, M., Komatsu, Y., et al. (2017) Comparison of Efficacy and Toxicity of FOLFIRINOX and Gemcitabine with Nab-Paclitaxel in Unresectable Pancreatic Cancer. Journal of Gastrointestinal Oncology, 8, 566-571.
https://doi.org/10.21037/jgo.2017.02.02
|
[34]
|
Han, Q., Deng, M., Lv, Y. and Dai, G. (2017) Survival of Patients with Advanced Pancreatic Cancer after Iodine 125 Seeds Implantation Brachytherapy: A Meta-Analysis. Medicine, 96, e5719.
https://doi.org/10.1097/MD.0000000000005719
|
[35]
|
Lauffer, D.C., Kuhn, P.A., Kueng, M., et al. (2018) Pancreatic Cancer: Feasibility and Outcome after Radiochemotherapy with High Dose External Radiotherapy for Non-Resected and R1 Resected Patients. Cureus, 10, 1-7. https://doi.org/10.7759/cureus.c14
|
[36]
|
Ma, N., Wang, Z., Zhao, J., et al. (2017) Improved Survival in Patients with Resected Pancreatic Carcinoma Using Postop-erative Intensity-Modulated Radiotherapy and Regional Intra-Arterial Infusion Chemotherapy. Medical Science Monitor, 23, 2315-2323. https://doi.org/10.12659/MSM.904393
|
[37]
|
Chiorean, E.G. and Coveler, A.L. (2015) Pancreatic Cancer: Optimizing Treatment Options, New, and Emerging Targeted Therapies. Drug Design, Devel-opment and Therapy, 9, 3529-3545. https://doi.org/10.2147/DDDT.S60328
|
[38]
|
Matsuoka, T. and Yashiro, M. (2016) Molecular Targets for the Treatment of Pancreatic Cancer: Clinical and Experimental Studies. World Journal of Gastroenterology, 22, 776-789. https://doi.org/10.3748/wjg.v22.i2.776
|
[39]
|
Furuse, J., Gemma, A., Ichikawa, W., Okusaka, T., Seki, A. and Ishii, T. (2017) Postmarketing Surveillance Study of Erlotinib plus Gem-citabine for Pancreatic Cancer in Japan: POLARIS Final Analysis. Japanese Journal of Clinical Oncology, 47, 832-839. https://doi.org/10.1093/jjco/hyx075
|
[40]
|
Vogl, T.J., Panahi, B., Albrecht, M.H., et al. (2018) Mi-crowave Ablation of Pancreatic Tumors. Minimally Invasive Therapy & Allied Technologies, 27, 33-40. https://doi.org/10.1080/13645706.2017.1420664
|
[41]
|
Strunk, H.M., Henseler, J., Rauch, M., et al. (2016) Clinical Use of High-Intensity Focused Ultrasound (HIFU) for Tumor and Pain Reduction in Advanced Pancreatic Cancer. RoFo, 188, 662-670.
https://doi.org/10.1055/s-0042-105517
|
[42]
|
Yang, Y. (2015) Cancer Immunotherapy: Harnessing the Immune System to Battle Cancer Find the Latest Version: Cancer Immunotherapy: Harnessing the Immune System to Battle Cancer. The Journal of Clinical Investigation, 125, 3335-3337. https://doi.org/10.1172/JCI83871
|
[43]
|
Sharpe, M.E. (2018) T-Cell Immunotherapies and the Role of Nonclinical Assessment: The Balance between Efficacy and Pathology. Toxicologic Pathology, 46, 131-146. https://doi.org/10.1177/0192623317752101
|